News

ThermoGenesis Holdings to Present at the H.C. Wainwright 25th Annual Global Investment Conference

RANCHO CORDOVA, Calif., September 6, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview on Wednesday, September 13, at 4:30 pm ET, during the H.C. Wainwright … Continued

ReadyStart CleanRooms and IncuStart Wet Labs

ReadyStart Cleanrooms and IncuStart Wet Labs Life as a Life Science Start-Up is not easy. We are working hard to make it little easier with our fully equipped, staffed, and maintained cleanrooms and wet labs are located in Northern California. Everything is under one roof within our over 35,000 sq-ft facility. With private offices and … Continued

ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., August 10, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the second quarter ended June 30, 2023, … Continued

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update

Conference Call to be Held on August 10, 2023 RANCHO CORDOVA, Calif., August 8, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced┬áthat the Company will release its financial results for the second quarter ended June 30, 2023, … Continued

ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

RANCHO CORDOVA, Calif., July 17, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced┬áthe appointments of Biao Xi, Ph.D. and James Xu, Esq., DBA, PsyD., J.D., CPA to its Board, effective July 17, 2023. Both are independent directors. … Continued

ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., May 15, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2023 … Continued

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update

Conference Call to be Held on May 15, 2023 RANCHO CORDOVA, Calif., May 10, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced┬áthat the Company will release its financial results for the first quarter ended March 31, 2023 … Continued

ThermoGenesis Holdings Announces Year End 2022 Financial Results and Provides Corporate Update

Conference Call to be Held Today at 1:30 p.m. PT/4:30 p.m. ET RANCHO CORDOVA, Calif., March 30, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the year ended December 31, 2022 and … Continued

ThermoGenesis Holdings to Announce Financial Results for the Year Ended December 31, 2022 and Provide a Corporate Strategic Update

Conference Call to be Held on March 30, 2023 RANCHO CORDOVA, Calif., March 28, 2023 — ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced┬áthat the Company will release its financial results for the year ended December 31, 2022 and provide a corporate strategic update … Continued

How may we help?